Predictors of high healthcare costs in elderly patients with liver cancer in end-of-life: a longitudinal population-based study

Table 3 Factors associated with HCs for elderly patients with liver cancer in their LML

Covariates	Estimate	O.R.	95% C.I.	p value
ICU	2.59	13.34	7.69–23.14	<0.001
Ventilator	1.24	3.46	2.04–5.87	<0.001
Anti-cancer treatments^a	1.00	2.72	1.60–4.62	<0.001
Admission days	0.22	1.25	1.21–1.30	<0.001
Admission times	−0.85	0.43	0.27–0.68	<0.001
CKD	1.07	2.92	1.44–5.93	0.003
EVB	0.81	2.26	1.17–4.36	0.015
Opioids use	0.61	1.85	1.17–2.91	0.009
Ascites	−1.08	0.34	0.20–0.59	<0.001
Hypertension	−0.52	0.59	0.36–0.99	0.046
Intercept	−6.92			<0.001

In this final model, 2049 cases (96.61%) were enrolled for analysis after excluding those (n = 72, 3.39%) with missing data
Abbreviations: ICU intensive care unit, CKD chronic kidney disease, EVB esophageal varices with bleeding
^aAnti-cancer treatments included TACE, Radiotherapy, Chemotherapy, HAIC, PEI, and RFA

ISSN: 1471-2407